Clinical trials for Acute biphenotypic leukemia
15 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- ENROLLING BY INVITATIONPhase 2NCT07517510HVA in the Treatment of Mixed-Phenotype Acute Leukemia(MPAL).Guangdong Second Provincial General Hospital
- RECRUITINGPHASE1, PHASE2NCT07356154A Study of Revumenib and Mezigdomide in People With LeukemiaMemorial Sloan Kettering Cancer Center · PI: Eytan Stein, MD
- RECRUITINGNCT07537738Leukemia Stem Cell-based Assay to Predict Relapse and Survival in Patients With Acute Myeloid LeukemiaPeking University People's Hospital
- RECRUITINGPHASE1, PHASE2NCT05589896A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic MalignanciesOssium Health, Inc.
- RECRUITINGN/ANCT05794880MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG DosingMedical College of Wisconsin
- ACTIVE NOT RECRUITINGPhase 2NCT03399773Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic SyndromesFred Hutchinson Cancer Center · PI: Filippo Milano
- RECRUITINGPHASE1, PHASE2NCT04797767Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid NeoplasmsUniversity of Washington · PI: Mary-Beth M. Percival
- ACTIVE NOT RECRUITINGPhase 2NCT04975919Venetoclax in Combination With Decitabine and Cedazuridine for the Treatment of Relapsed or Refractory Acute Myeloid LeukemiaM.D. Anderson Cancer Center · PI: Abhishek Maiti
- ACTIVE NOT RECRUITINGPhase 2NCT04128501Venetoclax and Azacitidine for the Treatment of Acute Myeloid Leukemia in the Post-Transplant SettingM.D. Anderson Cancer Center · PI: Betul Oran
- RECRUITINGPHASE1, PHASE2NCT04047641Cladribine, Idarubicin, Cytarabine, and Quizartinib in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromeM.D. Anderson Cancer Center · PI: Musa Yilmaz
- RECRUITINGPhase 2NCT03779854Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell TransplantFred Hutchinson Cancer Center · PI: Marie Bleakley
- RECRUITINGPhase 2NCT03683433Enasidenib and Azacitidine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia and IDH2 Gene MutationM.D. Anderson Cancer Center · PI: Courtney DiNardo
- RECRUITINGPhase 2NCT02727803Personalized NK Cell Therapy in CBTM.D. Anderson Cancer Center · PI: Amanda Olson, MD
- ACTIVE NOT RECRUITINGPhase 1NCT02159495Genetically Modified T-cell Immunotherapy in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia and Persistent/Recurrent Blastic Plasmacytoid Dendritic Cell NeoplasmCity of Hope Medical Center · PI: Lihua E. Budde
- RECRUITINGPhase 2NCT02115295Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid LeukemiaM.D. Anderson Cancer Center · PI: Tapan M Kadia